13-cis-retinoic acid,Isotretinoin

13-cis-retinoic acid,isotretinoin is a lipid of Prenol Lipids (PR) class. 13-cis-retinoic acid,isotretinoin is associated with abnormalities such as Dermatitis, Phototoxic. The involved functions are known as Regulation, Pigment, chromophore, Light absorption and Pupil constriction. 13-cis-retinoic acid,isotretinoin often locates in Neurosecretory Systems. The associated genes with 13-cis-retinoic acid,Isotretinoin are melanopsin.

Cross Reference

Introduction

To understand associated biological information of 13-cis-retinoic acid,Isotretinoin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 13-cis-retinoic acid,Isotretinoin?

13-cis-retinoic acid,Isotretinoin is suspected in Dermatitis, Phototoxic and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 13-cis-retinoic acid,Isotretinoin

MeSH term MeSH ID Detail
Lung Neoplasms D008175 171 associated lipids
Acne Vulgaris D000152 35 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Lymphoma, Large-Cell, Anaplastic D017728 3 associated lipids
Total 4

PubChem Associated disorders and diseases

What pathways are associated with 13-cis-retinoic acid,Isotretinoin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 13-cis-retinoic acid,Isotretinoin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 13-cis-retinoic acid,Isotretinoin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 13-cis-retinoic acid,Isotretinoin?

There are no associated biomedical information in the current reference collection.

What genes are associated with 13-cis-retinoic acid,Isotretinoin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 13-cis-retinoic acid,Isotretinoin?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 13-cis-retinoic acid,Isotretinoin

Download all related citations
Per page 10 20 50 100 | Total 2952
Authors Title Published Journal PubMed Link
Diffey BL et al. Photosensitivity studies and isotretinoin therapy. 1985 J. Am. Acad. Dermatol. pmid:3156899
Roenigk HH et al. Acne, retinoids, and dermabrasion. 1985 J Dermatol Surg Oncol pmid:3156902
Horton J Cancer prevention. 1985 J. Clin. Oncol. pmid:3859583
Lester RS et al. Isotretinoin and tetracycline in the management of severe nodulocystic acne. 1985 Int. J. Dermatol. pmid:3159698
Miller RA et al. Multiple granulation tissue lesions occurring in isotretinoin treatment of acne vulgaris--successful response to topical corticosteroid therapy. 1985 J. Am. Acad. Dermatol. pmid:3159762
Kassis I et al. Isotretinoin (Accutane) and pregnancy. 1985 Teratology pmid:3862261
Moy RL et al. Isotretinoin vs etretinate therapy in generalized pustular and chronic psoriasis. 1985 Arch Dermatol pmid:3862363
Lammer EJ et al. Retinoic acid embryopathy. 1985 N. Engl. J. Med. pmid:3162101
Chao WR et al. Comparison of the inhibitory effects of retinoids on 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activities in CD-1 and Sencar mice. 1985 Cancer Lett. pmid:3864525
McBride WG Limb reduction deformities in child exposed to isotretinoin in utero on gestation days 26-40 only. 1985 Lancet pmid:2860473
Lammer EJ et al. Does isotretinoin cause limb reduction defects? 1985 Lancet pmid:2862487
McBride WG Isotretinoin and reduction deformities. 1985 Lancet pmid:2863524
Loprinzi CL et al. Inhibition of phorbol ester--induced human epidermal ornithine decarboxylase activity by oral compounds: a possible role in human chemoprevention studies. 1985 J. Clin. Oncol. pmid:3859584
Zelickson AS et al. Ultrastructural changes in open comedones following treatment of cystic acne with isotretinoin. 1985 Am J Dermatopathol pmid:2413783
Dalziel K et al. The effects of isotretinoin on the pathology of early acne papules. 1985 Clin. Exp. Dermatol. pmid:2931217
Pochi PE Isotretinoin for acne: the experience broadens. 1985 N. Engl. J. Med. pmid:2931602
Bershad S et al. Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne. 1985 N. Engl. J. Med. pmid:2931603
Fraunfelder FT et al. Adverse ocular reactions possibly associated with isotretinoin. 1985 Am. J. Ophthalmol. pmid:2931989
Burton CS and Sawchuk WS Premature sebaceous gland hyperplasia: successful treatment with isotretinoin. 1985 J. Am. Acad. Dermatol. pmid:3855879
Meyskens FL et al. 13-Cis-retinoic acid: pharmacology, toxicology, and clinical applications for the prevention and treatment of human cancer. 1985 Crit. Rev. Oncol. Hematol. pmid:3893773
Larsen GK Iatrogenic breast discharge with isotretinoin. 1985 Arch Dermatol pmid:3856419
Colburn WA and Gibson DM Isotretinoin kinetics after 80 to 320 mg oral doses. 1985 Clin. Pharmacol. Ther. pmid:3856501
Arlin ZA et al. 13-cis-Retinoic acid does not increase the true remission rate and the duration of true remission (induced by cytotoxic chemotherapy) in patients with chronic phase chronic myelogenous leukemia. 1985 J. Clin. Oncol. pmid:3856630
Spielvogel RL et al. Oral isotretinoin therapy for familial Muir-Torre syndrome. 1985 J. Am. Acad. Dermatol. pmid:3857234
Lombardo JA et al. Strenuous exercise and elevated creatine phosphokinase in patients taking isotretinoin. 1985 J. Am. Acad. Dermatol. pmid:3857235
Lipinski JT and Schwimmer B Elevated CPK and isotretinoin. 1985 J. Am. Acad. Dermatol. pmid:3857236
James WD and Leyden JJ Treatment of gram-negative folliculitis with isotretinoin: positive clinical and microbiologic response. 1985 J. Am. Acad. Dermatol. pmid:3156159
Lucek RW and Colburn WA Clinical pharmacokinetics of the retinoids. 1985 Jan-Feb Clin Pharmacokinet pmid:3882304
Colburn WA et al. Pharmacokinetics of 14C-isotretinoin in healthy volunteers and volunteers with biliary T-tube drainage. 1985 May-Jun Drug Metab. Dispos. pmid:2861992
Shaw JC and White CR Treatment of multiple keratoacanthomas with oral isotretinoin. 1986 J. Am. Acad. Dermatol. pmid:3464625
Hazen PG et al. Corneal effect of isotretinoin: possible exacerbation of corneal neovascularization in a patient with the keratitis, ichthyosis, deafness ("KID") syndrome. 1986 J. Am. Acad. Dermatol. pmid:2419373
Hong WK et al. 13-cis-retinoic acid in the treatment of oral leukoplakia. 1986 N. Engl. J. Med. pmid:3537787
Rappaport IP et al. Erythrokeratodermia variabilis treated with isotretinoin. A clinical, histologic, and ultrastructural study. 1986 Arch Dermatol pmid:2420287
Katz RA Isotretinoin treatment of recalcitrant warts in an immunosuppressed man. 1986 Arch Dermatol pmid:3455807
Accutane-induced teratogenesis (correction) 1986 CMAJ pmid:3455831
Fontana JA et al. The role of 13 cis-retinoic acid in the remission induction of a patient with acute promyelocytic leukemia. 1986 Cancer pmid:3455835
Irving DW et al. Morphogenesis of isotretinoin-induced microcephaly and micrognathia studied by scanning electron microscopy. 1986 Teratology pmid:3465061
Jurecka W Erythrokeratodermia variabilis. 1986 Arch Dermatol pmid:3466575
Schewach-Millet M et al. Perifolliculitis capitis abscedens et suffodiens treated with isotretinoin (13-cis-retinoic acid) 1986 J. Am. Acad. Dermatol. pmid:3468134
Goldberg JD and Golbus MS The value of case reports in human teratology. 1986 Am. J. Obstet. Gynecol. pmid:3456709
Kilcoyne RF et al. Minimal spinal hyperostosis with low-dose isotretinoin therapy. 1986 Invest Radiol pmid:2935510
Hodak E et al. Muscle damage induced by isotretinoin. 1986 Br Med J (Clin Res Ed) pmid:3091143
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 17-1986. An 18-year-old man with cutaneous ulcers and bilateral pulmonary infiltrates. 1986 N. Engl. J. Med. pmid:2938008
Puig L et al. Granulation tissue proliferation during isotretinoin treatment. 1986 Int. J. Dermatol. pmid:2939033
Watson RR et al. Cellular immune functions of adults treated with a daily, long-term, low dose of 13-cis retinoic acid. 1986 J. Leukoc. Biol. pmid:2939161
Newton RC et al. Mechanism-oriented assessment of isotretinoin in chronic or subacute cutaneous lupus erythematosus. 1986 Arch Dermatol pmid:3511858
Picozzi VJ et al. 13-cis retinoic acid treatment for myelodysplastic syndromes. 1986 J. Clin. Oncol. pmid:3514807
Zelickson AS et al. Ultrastructural changes in sebaceous glands following treatment of cystic acne with isotretinoin. 1986 Am J Dermatopathol pmid:2940935
Marsden J Hyperlipidaemia due to isotretinoin and etretinate: possible mechanisms and consequences. 1986 Br. J. Dermatol. pmid:3516195
Giustina TA et al. Topical application of isotretinoin gel improves oral lichen planus. A double-blind study. 1986 Arch Dermatol pmid:3518638